4 hours Wake Up to This Biotech Stock That Still Has Big Potential Upside MarketBeat
Centessa Pharmaceuticals released strong results in Phase 1 trials and now Wall Street analysts are buzzing over the stock.
Biotech · Pharmaceuticals · Wall Street